Implementing provisions of the REACH Regulation1 has been a full-time job for both authorities and registrants for the last few years. The focus of activities so far has been the registration of substances and the subsequent compliance check of registration dossiers, with applications for authorization slowly coming to the fore in 2013. Likewise, registrants have, until now, not been concerned overmuch with the regulatory mechanism of substance evaluation under REACH. Now,